FDA Inspection 1269231 — Annora Pharma Private Limited
The FDA completed an inspection of Annora Pharma Private Limited on March 13, 2025 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 13, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Bioanalytical BA/BE